Comment
CEI Comments on Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program
Comments of the Competitive Enterprise Institute Dear Dr. Oz, The Competitive Enterprise Institute (CEI) submits these comments in support of several provisions…
Comment
CEI Comments on NIST’s Request for Information Regarding Security Considerations for Artificial Intelligence Agents
RE: Request for Information Regarding Security Considerations for Artificial Intelligence Agents Docket No.: NIST-2025-0035 The Competitive Enterprise Institute (CEI) appreciates the opportunity to…
Testimony
CEI’s Paige Lambermont testified this week before the House Science Subcommittee on policies driving U.S. AI growth
Chairman McCormick, Ranking Member Sykes, and distinguished members of the subcommittee, thank you for holding this hearing today and inviting me to testify.
Letters
Accountability in Action: Repeal the Center for Medicare and Medicaid Innovation
Dear Representative/Senator, We appreciate your leadership in advancing President Trump’s agenda to reduce government spending and restore accountability by reining in bureaucracy and…
Comment
CEI Comments on Global Benchmark for Efficient Drug Pricing (GLOBE) Model
Comments of the Competitive Enterprise Institute Dear Dr. Oz, The Competitive Enterprise Institute (CEI) submits these comments in opposition to the creation…
Legal Brief